Molecular docking study of Zingiber officinale Roscoe compounds as a mumps virus nucleoprotein inhibitor

Viol Dhea Kharisma, Santika Lusia Utami, Wahyu Choirur Rizky, Tim Godefridus Antonius Dings, Md Emdad Ullah, Vikash Jakhmola, Alexander Patera Nugraha

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)


Background: Mumps virus (MuV) can trigger severe infections, such as parotitis, epididymo-orchitis, and meningitis. The effectiveness of MuV vaccine administration has been proven, but current outbreaks warrant the development of antivirals against MuV. Zingiber officinale var. Roscoe or ginger is often used as an alternative remedy. Currently, there are no known in vitro or in vivo studies that investigate ginger as an MuV antiviral. Purpose: This study aims to evaluate the antiviral potency of the bioactive compounds in Zingiber officinale var. Roscoe against MuV. Methods: Antiviral activity screening was conducted by druglikeness analysis, antiviral probability, molecular docking, and molecular dynamic simulation. Results: As an antiviral, 6-shogaol from Zingiber officinale var. Roscoe has potency against MuV. It has a good binding affinity and can establish interactions with the binding domain of the target protein by forming hydrogen, Van der Waals, and alkyl bonds. Conclusion: The complex of 6-shogaol_NP was predicted to be volatile but stable for triggering inhibitory activity. However, these results must be proved by in vivo and in vitro approaches to strengthen the scientific evidence.

Original languageEnglish
Pages (from-to)23-29
Number of pages7
JournalDental Journal
Issue number1
Publication statusPublished - Mar 2023


  • Zingiber officinale
  • communicable disease
  • medicine
  • mumps
  • nucleoprotein


Dive into the research topics of 'Molecular docking study of Zingiber officinale Roscoe compounds as a mumps virus nucleoprotein inhibitor'. Together they form a unique fingerprint.

Cite this